US Stock MarketDetailed Quotes

APRE Aprea Therapeutics

Watchlist
  • 3.429
  • +0.100+3.01%
Close Aug 30 16:00 ET
  • 3.429
  • 0.0000.00%
Post 20:01 ET
18.62MMarket Cap-1139P/E (TTM)

Aprea Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
5.35%3.85M
-31.86%3.15M
-58.60%15.47M
38.59%3.67M
-16.13%3.52M
-83.73%3.65M
-42.75%4.62M
-0.20%37.37M
-66.13%2.65M
-55.46%4.2M
Selling and administrative expenses
8.95%1.85M
-42.67%1.93M
-59.81%8.43M
-22.49%1.64M
-44.21%1.72M
-89.13%1.7M
-15.54%3.37M
54.75%20.97M
-37.02%2.12M
-9.73%3.08M
-General and administrative expense
8.95%1.85M
-42.67%1.93M
-59.81%8.43M
-22.49%1.64M
-44.21%1.72M
-89.13%1.7M
-15.54%3.37M
54.75%20.97M
-37.02%2.12M
-9.73%3.08M
Research and development costs
16.12%2.56M
27.36%1.6M
-53.50%7.63M
284.96%2.05M
89.93%2.12M
-67.66%2.2M
-69.27%1.26M
-31.36%16.4M
-88.09%531.41K
-81.42%1.12M
Other operating expenses
-124.91%-561.57K
---380.57K
---583.23K
---14.08K
---319.47K
---249.69K
----
----
----
----
Operating profit
-5.35%-3.85M
31.86%-3.15M
58.60%-15.47M
-38.59%-3.67M
16.13%-3.52M
83.73%-3.65M
42.75%-4.62M
0.20%-37.37M
66.13%-2.65M
55.46%-4.2M
Net non-operating interest income expense
13.73%382.37K
10.53%283.4K
172.84%1.22M
27.65%310.29K
112.55%321.22K
540.53%336.22K
12,909.13%256.41K
27,124.94%448.67K
7,208.54%243.08K
458,048.48%151.12K
Non-operating interest income
13.73%382.37K
10.53%283.4K
172.84%1.22M
27.65%310.29K
112.55%321.22K
540.53%336.22K
--256.41K
27,124.94%448.67K
--243.08K
--151.12K
Other net income (expense)
-109.76%-5.5K
507.16%56.18K
99.95%-38.93K
-133.99%-78.61K
-111.83%-2.88K
100.07%56.36K
-110.13%-13.8K
-23,962.06%-75.74M
-147.88%-33.6K
211.17%24.35K
Gain on sale of security
-109.76%-5.5K
507.16%56.18K
-113.83%-38.93K
-133.99%-78.61K
-111.83%-2.88K
-63.53%56.36K
-110.13%-13.8K
-11.30%281.53K
-147.88%-33.6K
211.17%24.35K
Special income (charges)
----
----
--0
--0
--0
----
----
---76.02M
--0
--0
-Less:Other special charges
----
----
----
----
----
----
----
--76.02M
--0
----
Income before tax
-6.47%-3.47M
35.84%-2.81M
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
57.42%-4.02M
Income tax
Net income
-6.47%-3.47M
35.84%-2.81M
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
57.42%-4.02M
Net income continuous Operations
-6.47%-3.47M
35.84%-2.81M
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
57.42%-4.02M
Minority interest income
Net income attributable to the parent company
-6.47%-3.47M
35.84%-2.81M
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
57.42%-4.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-6.47%-3.47M
35.84%-2.81M
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
57.42%-4.02M
Basic earnings per share
33.33%-0.58
50.00%-0.67
94.19%-3.95
0.00%-0.92
62.93%-0.86
99.00%-0.87
81.52%-1.34
-94.93%-67.99
87.22%-0.92
74.22%-2.32
Diluted earnings per share
33.33%-0.58
50.00%-0.67
94.19%-3.95
0.00%-0.92
62.93%-0.86
99.00%-0.87
81.52%-1.34
-94.93%-67.99
87.22%-0.92
74.22%-2.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 5.35%3.85M-31.86%3.15M-58.60%15.47M38.59%3.67M-16.13%3.52M-83.73%3.65M-42.75%4.62M-0.20%37.37M-66.13%2.65M-55.46%4.2M
Selling and administrative expenses 8.95%1.85M-42.67%1.93M-59.81%8.43M-22.49%1.64M-44.21%1.72M-89.13%1.7M-15.54%3.37M54.75%20.97M-37.02%2.12M-9.73%3.08M
-General and administrative expense 8.95%1.85M-42.67%1.93M-59.81%8.43M-22.49%1.64M-44.21%1.72M-89.13%1.7M-15.54%3.37M54.75%20.97M-37.02%2.12M-9.73%3.08M
Research and development costs 16.12%2.56M27.36%1.6M-53.50%7.63M284.96%2.05M89.93%2.12M-67.66%2.2M-69.27%1.26M-31.36%16.4M-88.09%531.41K-81.42%1.12M
Other operating expenses -124.91%-561.57K---380.57K---583.23K---14.08K---319.47K---249.69K----------------
Operating profit -5.35%-3.85M31.86%-3.15M58.60%-15.47M-38.59%-3.67M16.13%-3.52M83.73%-3.65M42.75%-4.62M0.20%-37.37M66.13%-2.65M55.46%-4.2M
Net non-operating interest income expense 13.73%382.37K10.53%283.4K172.84%1.22M27.65%310.29K112.55%321.22K540.53%336.22K12,909.13%256.41K27,124.94%448.67K7,208.54%243.08K458,048.48%151.12K
Non-operating interest income 13.73%382.37K10.53%283.4K172.84%1.22M27.65%310.29K112.55%321.22K540.53%336.22K--256.41K27,124.94%448.67K--243.08K--151.12K
Other net income (expense) -109.76%-5.5K507.16%56.18K99.95%-38.93K-133.99%-78.61K-111.83%-2.88K100.07%56.36K-110.13%-13.8K-23,962.06%-75.74M-147.88%-33.6K211.17%24.35K
Gain on sale of security -109.76%-5.5K507.16%56.18K-113.83%-38.93K-133.99%-78.61K-111.83%-2.88K-63.53%56.36K-110.13%-13.8K-11.30%281.53K-147.88%-33.6K211.17%24.35K
Special income (charges) ----------0--0--0-----------76.02M--0--0
-Less:Other special charges ------------------------------76.02M--0----
Income before tax -6.47%-3.47M35.84%-2.81M87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M57.42%-4.02M
Income tax
Net income -6.47%-3.47M35.84%-2.81M87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M57.42%-4.02M
Net income continuous Operations -6.47%-3.47M35.84%-2.81M87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M57.42%-4.02M
Minority interest income
Net income attributable to the parent company -6.47%-3.47M35.84%-2.81M87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M57.42%-4.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -6.47%-3.47M35.84%-2.81M87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M57.42%-4.02M
Basic earnings per share 33.33%-0.5850.00%-0.6794.19%-3.950.00%-0.9262.93%-0.8699.00%-0.8781.52%-1.34-94.93%-67.9987.22%-0.9274.22%-2.32
Diluted earnings per share 33.33%-0.5850.00%-0.6794.19%-3.950.00%-0.9262.93%-0.8699.00%-0.8781.52%-1.34-94.93%-67.9987.22%-0.9274.22%-2.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg